| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-09 |
| mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-06 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |